Supreme Court Rejects Plea Alleging Side Effects Of COVID-19 Vaccines

New Delhi:  The Supreme Court of India on Monday dismissed a petition alleging that COVID-19 vaccines caused severe side effects, including blood clotting, calling the plea as an attempt to create unnecessary alarm.

A bench led by Chief Justice DY Chandrachud, along with Justices JB Pardiwala and Manoj Misra, declined to entertain the petition, stating that it lacked merit. “We don’t want to rake this up. This is just to create a sensation,” remarked the bench, questioning the usefulness of the petition.

The court further highlighted the broader implications, suggesting that public health efforts might have been compromised if people had refrained from taking the vaccine.

During the proceedings, the court directly questioned the petitioner’s lawyer on whether he had taken the vaccine. After confirming that he had received the vaccine and experienced no side effects, the bench emphasized the lack of merit in the case.

The petition was filed by Priya Mishra and others, who sought to challenge the alleged adverse effects of the COVID-19 vaccination drive.

Case Details: PRIYA MISHRA AND ANR. vs UNION OF INDIA AND ORS., Diary No. 22945-2024

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year